Business Context and Reporting Period
This Form 8-K, dated January 4, 2008, reports on Greatbatch, Inc. (not Integer Holdings Corp as indicated in metadata), a Delaware corporation. The filing details the completion of the acquisition of P Medical Holding SA ("Precimed"), a Swiss-based technology supplier to the orthopedic industry, which closed on January 7, 2008.
Key Financial Metrics and Transaction Details
- Acquisition Price: Approximately CHF 123,000,000 in cash, subject to an indebtedness adjustment.
- Contingent Payment: Potential additional payment ranging from CHF 0 to CHF 12,000,000 based on Precimed's 2008 earnings performance.
- Escrow: Approximately CHF 8,000,000 placed in escrow for indemnification claims.
- Financing: Funded via cash on hand and a new borrowing of approximately $102 million under an existing revolving credit agreement.
- Interest Terms: Borrowing bears interest based on Prime Rate (margin -1.25% to 0.00%) or LIBOR (margin 1.00% to 2.00%), varying by leverage ratio.
Material Changes and Significant Events
The primary material change is the expansion of Greatbatch's operations through the acquisition of Precimed. Additionally, the transaction includes the assumption of Precimed's rights and obligations to acquire another orthopedic industry company, expected to close in early 2008. Greatbatch determined that Precimed does not meet the definition of a "significant subsidiary" under Regulation S-X, exempting the company from filing audited financial statements or pro forma financial information for the acquired entity.
Outlook, Risks, and Management Commentary
Management views Precimed as a leading technology-driven supplier, enhancing Greatbatch's position in the orthopedic sector. The filing notes that the contingent payment structure aligns future costs with Precimed's 2008 performance. No specific forward-looking revenue guidance or risk factors beyond standard transaction contingencies (such as the escrow and contingent payment) are detailed in this specific report.
Investor Verification Checklist
- Verify the final purchase price after the "Indebtedness Adjustment" is calculated.
- Monitor Precimed's 2008 earnings performance to determine the final contingent payment amount.
- Review the status of the secondary acquisition of another orthopedic company assumed by Greatbatch.
- Assess the impact of the $102 million debt increase on Greatbatch's leverage ratio and future interest expenses.